Klebsiella MALDI TypeR: a web-based tool for Klebsiella identification based on MALDI-TOF mass spectrometry.


Journal

Research in microbiology
ISSN: 1769-7123
Titre abrégé: Res Microbiol
Pays: France
ID NLM: 8907468

Informations de publication

Date de publication:
Historique:
received: 01 04 2021
accepted: 10 05 2021
pubmed: 19 5 2021
medline: 12 11 2021
entrez: 18 5 2021
Statut: ppublish

Résumé

Klebsiella pathogens affect human and animal health and are widely distributed in the environment. Among these, the Klebsiella pneumoniae species complex, which includes seven phylogroups, is an important cause of community and hospital infections. The Klebsiella oxytoca species complex also causes hospital infections and antibiotic-associated haemorrhagic colitis. The unsuitability of currently used clinical microbiology methods to distinguish species within each of these species complexes leads to high rates of misidentifications that are masking the true clinical significance and potential epidemiological specificities of individual species. We developed a web-based tool, Klebsiella MALDI TypeR, a platform-independent and user-friendly application that enables uploading MALDI-TOF mass spectrometry data in order to identify Klebsiella isolates at the species complex and phylogroup levels. The tool, available at https://maldityper.pasteur.fr/, leverages a database of previously identified biomarkers that are specific for species complexes, individual phylogroups, or related phylogroups. We obtained 84%-100% identification accuracy depending on phylogroup. Identification results are obtained in a few seconds from batches of uploaded spectral data. Klebsiella MALDI TypeR enables fast and reliable identification of Klebsiella strains that are often misidentified with standard microbiological methods. This web-based identification tool may be extended in the future to other human bacterial pathogens.

Identifiants

pubmed: 34004273
pii: S0923-2508(21)00049-8
doi: 10.1016/j.resmic.2021.103835
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

103835

Informations de copyright

Copyright © 2021 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.

Auteurs

Sébastien Bridel (S)

Biodiversity and Epidemiology of Bacterial Pathogens, Institut Pasteur, Paris, France.

Stephen C Watts (SC)

Department of Infectious Diseases, Central Clinical School, Monash University, Melbourne, Victoria, 3004, Australia.

Louise M Judd (LM)

Department of Infectious Diseases, Central Clinical School, Monash University, Melbourne, Victoria, 3004, Australia.

Taylor Harshegyi (T)

Department of Infectious Diseases, Central Clinical School, Monash University, Melbourne, Victoria, 3004, Australia.

Virginie Passet (V)

Biodiversity and Epidemiology of Bacterial Pathogens, Institut Pasteur, Paris, France.

Carla Rodrigues (C)

Biodiversity and Epidemiology of Bacterial Pathogens, Institut Pasteur, Paris, France.

Kathryn E Holt (KE)

Department of Infectious Diseases, Central Clinical School, Monash University, Melbourne, Victoria, 3004, Australia; London School of Hygiene & Tropical Medicine, London, WC1E 7HT, UK.

Sylvain Brisse (S)

Biodiversity and Epidemiology of Bacterial Pathogens, Institut Pasteur, Paris, France. Electronic address: sylvain.brisse@pasteur.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH